Experienced in Gastritis

Yandi Liu

Tianjin Union Medical Center, 
Changhongjie, CN 
Experienced in Gastritis
Tianjin Union Medical Center, 
Changhongjie, CN 
OverviewLocationsClinical Research

Overview

Yandi Liu practices in Changhongjie, China. Ms. Liu is rated as an Experienced expert by MediFind in the treatment of Gastritis. Her top areas of expertise are Gastritis, Viral Gastroenteritis, Chronic Idiopathic Constipation (CIC), and Peptic Ulcer.

Her clinical research consists of co-authoring 13 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of Gastritis.

Gender
Female

Locations

Tianjin Union Medical Center, Changhongjie, 300121, China
Other Locations
Tianjin Union Medical Center
Tianjin, 300121, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
Enrollment Status: Completed
Publish Date: December 27, 2024
Intervention Type: Drug
Study Drugs: Mirikizumab, Ustekinumab
Study Phase: Phase 3
A Prospective, Multicenter, Single-arm, Observational Study to Evaluate the Safety and Effectiveness of Vedolizumab in Real-World Clinical Practice in China
A Prospective, Multicenter, Single-arm, Observational Study to Evaluate the Safety and Effectiveness of Vedolizumab in Real-World Clinical Practice in China
Enrollment Status: Completed
Publish Date: July 22, 2024
View 1 Less Clinical Trial

13 Total Publications

Fecal metabolomics in Crohn's disease reveal N-Acetylglutamine as a Th17/Treg modulator.
Fecal metabolomics in Crohn's disease reveal N-Acetylglutamine as a Th17/Treg modulator.
Journal: Molecular immunology
Published: October 29, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Liu's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile